{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:30:18Z","timestamp":1792668618097,"version":"4.5.0"},"reference-count":14,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"DOI":"10.1182\/bloodadvances.2022007812","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T14:13:33Z","timestamp":1655993613000},"page":"4553-4557","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":61,"title":["Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-4802","authenticated-orcid":false,"given":"Meghan C.","family":"Thompson","sequence":"first","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary A.","family":"Harrup","sequence":"additional","affiliation":[{"name":"2Royal Hobart Hospital, Tasmania, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Coombs","sequence":"additional","affiliation":[{"name":"3University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3806-059X","authenticated-orcid":false,"given":"Lindsey E.","family":"Roeker","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-3159","authenticated-orcid":false,"given":"Jeffrey J.","family":"Pu","sequence":"additional","affiliation":[{"name":"4University of Arizona Cancer Center, Tuscon, AZ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.","family":"Choi","sequence":"additional","affiliation":[{"name":"5University of California, San Diego, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-401X","authenticated-orcid":false,"given":"Paul M.","family":"Barr","sequence":"additional","affiliation":[{"name":"6Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2088-0899","authenticated-orcid":false,"given":"John N.","family":"Allan","sequence":"additional","affiliation":[{"name":"7Weill Cornell Medicine, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-5334","authenticated-orcid":false,"given":"Martin","family":"\u0160imkovi\u010d","sequence":"additional","affiliation":[{"name":"8University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Leslie","sequence":"additional","affiliation":[{"name":"9Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Rhodes","sequence":"additional","affiliation":[{"name":"10Northwell Health Cancer Institute, Lake Success, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8895-1625","authenticated-orcid":false,"given":"Elise A.","family":"Chong","sequence":"additional","affiliation":[{"name":"11University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Kamdar","sequence":"additional","affiliation":[{"name":"12University of Colorado Cancer Center, Denver, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Skarbnik","sequence":"additional","affiliation":[{"name":"13Novant Health, Charlotte, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Lansigan","sequence":"additional","affiliation":[{"name":"14Dartmouth-Hitchcock Medical Center, Lebanon, NH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"McCall","sequence":"additional","affiliation":[{"name":"14Dartmouth-Hitchcock Medical Center, Lebanon, NH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0271-8732","authenticated-orcid":false,"given":"Khalid","family":"Saja","sequence":"additional","affiliation":[{"name":"15Colchester General Hospital, East Suffolk, and North Essex NHS Foundation Trust, Essex, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-2236","authenticated-orcid":false,"given":"Martin J. S.","family":"Dyer","sequence":"additional","affiliation":[{"name":"16The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-711X","authenticated-orcid":false,"given":"Harriet S.","family":"Walter","sequence":"additional","affiliation":[{"name":"16The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Lefebure","sequence":"additional","affiliation":[{"name":"17Roche Products Ltd, Welwyn Garden City, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Thadani-Mulero","sequence":"additional","affiliation":[{"name":"17Roche Products Ltd, Welwyn Garden City, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Boyer","sequence":"additional","affiliation":[{"name":"17Roche Products Ltd, Welwyn Garden City, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Biondo","sequence":"additional","affiliation":[{"name":"18Genentech, Inc., South San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Sail","sequence":"additional","affiliation":[{"name":"19AbbVie, Inc., North Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenish S.","family":"Manzoor","sequence":"additional","affiliation":[{"name":"19AbbVie, Inc., North Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Furman","sequence":"additional","affiliation":[{"name":"7Weill Cornell Medicine, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt S.","family":"Bantilan","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5125-6522","authenticated-orcid":false,"given":"Andre","family":"Goy","sequence":"additional","affiliation":[{"name":"9Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Feldman","sequence":"additional","affiliation":[{"name":"9Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-9538","authenticated-orcid":false,"given":"Dominic","family":"Labella","sequence":"additional","affiliation":[{"name":"20Riverside Regional Medical Center, Newport News, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-8978","authenticated-orcid":false,"given":"Stephen J.","family":"Schuster","sequence":"additional","affiliation":[{"name":"11University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae","family":"Park","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Palomba","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1403-6883","authenticated-orcid":false,"given":"Andrew","family":"Zelenetz","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-9749","authenticated-orcid":false,"given":"Toby A.","family":"Eyre","sequence":"additional","affiliation":[{"name":"21Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-1891","authenticated-orcid":false,"given":"Arnon P.","family":"Kater","sequence":"additional","affiliation":[{"name":"22Amsterdam University Medical Centers, Amsterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2188-6835","authenticated-orcid":false,"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[{"name":"23Royal Melbourne Hospital, Peter McCallum Cancer Centre, and University of Melbourne, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Mato","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"4","key":"2022080415262538000_B1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N Engl J Med."},{"issue":"12","key":"2022080415262538000_B2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1713976","article-title":"Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia","volume":"378","author":"Seymour","year":"2018","journal-title":"N Engl J Med."},{"issue":"23","key":"2022080415262538000_B3","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1815281","article-title":"Venetoclax and obinutuzumab in patients with CLL and coexisting conditions","volume":"380","author":"Fischer","year":"2019","journal-title":"N Engl J Med."},{"issue":"9","key":"2022080415262538000_B4","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(20)30443-5","article-title":"Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial","volume":"21","author":"Al-Sawaf","year":"2020","journal-title":"Lancet Oncol."},{"issue":"4","key":"2022080415262538000_B5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1200\/JCO.18.01580","article-title":"Fixed duration of venetoclax-rituximab in relapsed\/refractory chronic lymphocytic leukemia eradicates minimal residual disease and prolongs survival: post-treatment follow-up of the MURANO phase III study","volume":"37","author":"Kater","year":"2019","journal-title":"J Clin Oncol."},{"issue":"10","key":"2022080415262538000_B6","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood.2020009578","article-title":"Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited-duration therapy","volume":"138","author":"Ma","year":"2021","journal-title":"Blood."},{"key":"2022080415262538000_B7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2020-137415","article-title":"Efficacy of subsequent novel targeted therapies, including repeated venetoclax-rituximab (VenR), in patients (Pts) with relapsed\/refractory chronic lymphocytic leukemia (R\/R CLL) previously treated with fixed-duration Venr in the Murano Study","volume":"136","author":"Harrup","year":"2020","journal-title":"Blood."},{"issue":"25","key":"2022080415262538000_B8","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood."},{"key":"2022080415262538000_B9","year":"2021"},{"key":"2022080415262538000_B10","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-21-1237","article-title":"Recognizing unmet need in the era of targeted therapy for CLL\/SLL: \u201cwhat\u2019s past is prologue\u201d (Shakespeare)","author":"Mato","year":"2022","journal-title":"Clin Cancer Res."},{"issue":"20","key":"2022080415262538000_B11","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/bloodadvances.2021005083","article-title":"Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition","volume":"5","author":"Lew","year":"2021","journal-title":"Blood Adv."},{"issue":"14","key":"2022080415262538000_B12","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/1078-0432.CCR-19-3815","article-title":"Assessment of the efficacy of therapies following venetoclax discontinuation in CLL reveals BTK inhibition as an effective strategy","volume":"26","author":"Mato","year":"2020","journal-title":"Clin Cancer Res."},{"key":"2022080415262538000_B13","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1182\/blood-2021-150751","article-title":"Addressing a new challenge in chronic lymphocytic leukemia: outcomes of therapies after exposure to both a covalent Bruton\u2019s tyrosine kinase inhibitor and venetoclax","volume":"138","author":"Thompson","year":"2021","journal-title":"Blood."},{"issue":"5","key":"2022080415262538000_B14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1182\/blood.2020008502","article-title":"How I treat chronic lymphocytic leukemia after venetoclax","volume":"138","author":"Lew","year":"2021","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/15\/4553\/1912116\/advancesadv2022007812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/15\/4553\/1912116\/advancesadv2022007812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T15:27:48Z","timestamp":1659626868000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/15\/4553\/485664\/Venetoclax-retreatment-of-patients-with-chronic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":14,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,8,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007812","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]}}}